SCHEMBL31723158

SCHEMBL31723158

Cc1cccc(-c2oc3cc(C)ccc3c(=O)c2C(=O)O)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.68
KDM4E B2RXH2 7/20 0.68
ALDH1A1 P00352 6/20 0.68
HPGD P15428 4/20 0.68
MEN1 O00255 3/20 0.68
KMT2A Q03164 3/20 0.68
SMN1; SMN2 Q16637 2/20 0.68
HTT P42858 2/20 0.68
NPC1 O15118 1/20 0.68
RAB9A P51151 1/20 0.68
CYP3A4 P08684 4/20 0.47
TDP1 Q9NUW8 2/20 0.47
TSHR P16473 2/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
CA12 O43570 1/20 0.45
CA9 Q16790 1/20 0.45
TP53 P04637 4/20 0.44
CSNK2A2 P19784 1/20 0.44
CSNK2B P67870 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28431175 1.00 MAPT (0.68) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL28427603 0.90 MAPT (0.62) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL31723167 0.90 MAPT (0.62) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL31723140 0.90 MAPT (0.59) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL20919306 0.90 MAPT (0.59) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL31723137 0.90 KDM4E (0.72) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL20918213 0.90 MAPT (0.85) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL31723182 0.90 MAPT (0.85) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL28429262 0.90 KDM4E (0.72) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL31723148 0.88 ALDH1A1 (0.57) MAPTKDM4EALDH1A1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3699174-B1 COMPOSITION FOR PREVENTING OR TREATING TNF-RELATED DISEASES, CONTAINING DERIVATIVE AS ACTIVE INGREDIENT, AND METHOD FOR INHIBITING TNF ACTIVITY BY USING SAME ILAB (KR) 2025-11-12 EP claimed